Sign in
4

Changes in Ownership

RxSight, Inc. Filed Acc 0000950170-24-008423

Chief Financial Officer sold 31,772 shares at $47.11 ($1,496,706)

  • Chief Financial Officer acquired 36,272 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Thunen Shelley B Chief Financial Officer 2024-01-26 Option exercise +4,500 $4.34 $19,530 6,791 D
Thunen Shelley B Chief Financial Officer 2024-01-26 Option exercise +31,772 $15.08 $479,122 38,563 D
Thunen Shelley B Chief Financial Officer 2024-01-26 Sale −31,772 $47.11 $1,496,706 6,791 D
Derivatives
Thunen Shelley B Chief Financial Officer 2024-01-26 Option exercise · Stock Option (right to buy) −4,500 24,540 D
Thunen Shelley B Chief Financial Officer 2024-01-26 Option exercise · Stock Option (right to buy) −31,772 16,629 D
Open-market sales · 31,772 sh · avg $47.11 · $1,496,706
Loading xslF345X05/ownership.xml…